Tibet Rhodiola Pharmaceutical Holding Co.
SHH: 600211.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yuan Dong Guo
- Employees
- 596
- Headquarters
- Lhasa, China
- IPO year
- 1999
- Market cap
- CN¥13.5B
- Website
- https://www.xzyy.cn
Loading 600211…
Loading profile data…Frequently asked questions about 600211
What does Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) do?
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
Where does 600211.SS trade?
Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) trades on the Shanghai Stock Exchange.
What sector is 600211.SS in?
Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tibet Rhodiola Pharmaceutical Holding Co.?
Yuan Dong Guo is the chief executive officer of Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS).
Where is Tibet Rhodiola Pharmaceutical Holding Co. headquartered?
Tibet Rhodiola Pharmaceutical Holding Co. is headquartered in China.
Does 600211.SS pay a dividend?
Yes — Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) paid a trailing twelve-month dividend of CNY 0.88 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600211.SS go public?
Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) completed its initial public offering in 1999.